Feb 24, 2020

Huntsman Cancer Institute Translational Scholars: Benjamin L. Maughan, MD, PharmD

Huntsman Cancer Institute has established The Society of Huntsman Translational Scholars, an initiative that recognizes excellence in the discipline of translational science. Benjamin L. Maughan, MD, PharmD, was recently honored with a Huntsman Translational Scholar award.

Feb 21, 2020

Chasing—and Catching—His Dreams

To say that the PathMaker Program made an impact on my life would be a huge understatement. I learned so much from my PathMaker experience, I honestly could write a book about it. Because of the skills I learned, the connections I made, and the amazing mentorship I received, the program instilled in me a drive to continue to chase my dreams.

Feb 20, 2020

Huntsman Cancer Institute to Host 7th Annual Metastatic Breast Cancer Research Conference

The 7th annual Metastatic Breast Cancer Research Conference will be hosted by Huntsman Cancer Institute at the University of Utah in partnership with Baylor College of Medicine and Theresa’s Research Foundation on September 10 and 11, 2020. Participants from around the world are invited to discuss metastatic breast cancer including ongoing research and new ideas from early career scientists.

Feb 18, 2020

Huntsman Cancer Institute Launches New Cancer Genetics Center

A new research initiative at Huntsman Cancer Institute at the University of Utah builds upon Utah’s history of genetic discovery to inform strategies that help affected families reduce their cancer risk. Called the Center for Cancer Genetics at HCI, its initial work includes two statewide projects designed to advance understanding of genetic predisposition of cancer and other disease.

Feb 11, 2020

Researchers Discover a Key Protein in Endometrial Cancer Growth

The hormone estrogen plays many critical roles in men and women, in both healthy tissues and in cancer. In breast and gynecologic cancers, estrogen sends signals to tumors instructing the cancer cells to grow out of control. . In endometrial cancer, which arises in the lining of the uterus, estrogen is known to play a critical role in tumor development, yet many insights from how it affects breast cancer do not apply to endometrial cancer. New research from HCI Researchers outlines findings scientists hope will advance our understanding of endometrial cancer and lead to more effective treatments.

Feb 07, 2020

New CAR-T Target Yields Promising Results for Multiple Myeloma

Too many patients with cancers like multiple myeloma relapse after treatment. This grim reality motivated researchers at HCI to try to improve the depth and durability of treatment response in multiple myeloma through a new cancer cell targeting mechanism. In research published in the journal Nature Communications, HCI scientists describe a novel way to treat cancers using chimeric antigen receptor (CAR) T cell therapy.

Feb 07, 2020

HCI Researcher Receives Award to Study Skin Cancer Prevention Behaviors in Children and Families

Yelena Wu, PhD, has been awarded a multi-year Research Scholar Grant totaling nearly $800,000. This award, given by the American Cancer Society, will expand Dr. Wu’s work to rigorously test new behavioral interventions to promote implementation of skin cancer prevention behaviors among Utah children and their parents.

Jan 24, 2020

Two HCI Researchers Receive Prestigious Grant to Study Liver Cancer

Kimberley Evason, MD, PhD, and Gregory Ducker, PhD, were two of only twelve scientists nationwide to receive a Damon Runyon-Rachleff Innovation Award. This award is given by the Damon Runyon Cancer Research Foundation annually to help “exceptionally creative thinkers” who pursue “high-risk, high-reward” research concepts.